Rite Aid (RAD) Stock Forecast, Price & News

Rite Aid (NYSE:RAD) Frequently Asked Questions

Is Rite Aid a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last twelve months. There are currently 3 sell ratings for the stock. The consensus among Wall Street research analysts is that investors should "sell" Rite Aid stock.
View analyst ratings for Rite Aid or view top-rated stocks.

When is Rite Aid's next earnings date?

Rite Aid is scheduled to release its next quarterly earnings announcement on Thursday, June 23rd 2022.
View our earnings forecast for Rite Aid.

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) posted its quarterly earnings data on Thursday, April, 14th. The company reported ($1.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.57) by $1.06. The business had revenue of $6.07 billion for the quarter, compared to the consensus estimate of $5.96 billion. Rite Aid had a negative trailing twelve-month return on equity of 19.38% and a negative net margin of 2.19%. Rite Aid's revenue for the quarter was up 2.5% compared to the same quarter last year. During the same period last year, the business posted ($0.78) earnings per share.
View Rite Aid's earnings history.

When did Rite Aid's stock split? How did Rite Aid's stock split work?

Rite Aid's stock reverse split before market open on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

What guidance has Rite Aid issued on next quarter's earnings?

Rite Aid updated its FY23 earnings guidance on Thursday, April, 14th. The company provided EPS guidance of ($1.06)-($0.53) for the period, compared to the consensus estimate of ($1.22). The company issued revenue guidance of $23.1-23.5 billion, compared to the consensus revenue estimate of $23.44 billion.

What price target have analysts set for RAD?

3 Wall Street analysts have issued twelve-month price objectives for Rite Aid's stock. Their forecasts range from $2.00 to $12.00. On average, they anticipate Rite Aid's share price to reach $8.33 in the next twelve months. This suggests a possible upside of 49.1% from the stock's current price.
View analysts' price targets for Rite Aid or view top-rated stocks among Wall Street analysts.

Who are Rite Aid's key executives?

Rite Aid's management team includes the following people:

• Ms. Heyward Rutledge Donigan B.A., Pres, CEO & Director (Age 61, Pay $2.18M)
• Mr. Matthew C. Schroeder, CFO & Exec. VP (Age 52, Pay $1.17M)
• Mr. Justin L. Mennen, Chief Technology & Digital Officer (Age 41, Pay $731.15k)
• Mr. Brian T. Hoover, Chief Accounting Officer & Sr. VP (Age 57)
• Byron Purcell, Sr. Director of Treasury Services & Investor Relations
• Mr. Trent Kruse, Sr. VP of Investor Relations & Treasury
• Mr. Paul D. Gilbert, Exec. VP, Gen. Counsel & Corp. Sec. (Age 55)
• Ms. Susan K. Henderson, Chief Communications Officer & Sr. VP (Age 69)
• Mr. Frank G. Vitrano, Chief Strategic Bus. Devel. Officer (Age 67)
• Ms. Jessica Kazmaier, Exec. VP & Chief HR Officer (Age 44)

What is Heyward Donigan's approval rating as Rite Aid's CEO?

169 employees have rated Rite Aid CEO Heyward Donigan on Glassdoor.com. Heyward Donigan has an approval rating of 58% among Rite Aid's employees. This puts Heyward Donigan in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Rite Aid's key competitors?

Some companies that are related to Rite Aid include PetMed Express (PETS), 111 (YI), MedAvail (MDVL), General Cannabis (CANN), Progressive Care (RXMD), HealthWarehouse.com (HEWA), China Jo-Jo Drugstores (CJJD), China Dasheng Biotechnology (CDBT), Dougherty's Pharmacy (MYDP), Dragon Jade International (DGJI) and Health Sciences Group (HESG).
View all of RAD's competitors.

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), (CELG), Bank of America (BAC), Akorn (AKRX), Advanced Micro Devices (AMD), Cleveland-Cliffs (CLF), Mr. Cooper Group (COOP), General Electric (GE), Micron Technology (MU) and CVS Health (CVS).

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

Who are Rite Aid's major shareholders?

Rite Aid's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.10%), BlackRock Inc. (8.84%), Invesco Ltd. (5.03%), Dimensional Fund Advisors LP (3.14%), State Street Corp (3.04%) and JPMorgan Chase & Co. (1.94%). Company insiders that own Rite Aid stock include Heyward R Donigan and Jocelyn Z Konrad.
View institutional ownership trends for Rite Aid.

Which major investors are selling Rite Aid stock?

RAD stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., UBS Group AG, Group One Trading L.P., State Street Corp, Walleye Capital LLC, Citigroup Inc., Simplex Trading LLC, and Bank of New York Mellon Corp.
View insider buying and selling activity for Rite Aid or view top insider-selling stocks.

Which major investors are buying Rite Aid stock?

RAD stock was acquired by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Vanguard Group Inc., JPMorgan Chase & Co., BlackRock Inc., Federated Hermes Inc., PDT Partners LLC, Renaissance Technologies LLC, and Engineers Gate Manager LP.
View insider buying and selling activity for Rite Aid or or view top insider-buying stocks.

How do I buy shares of Rite Aid?

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $5.59.

How much money does Rite Aid make?

Rite Aid has a market capitalization of $311.07 million and generates $24.57 billion in revenue each year. The company earns $-538.48 million in net income (profit) each year or ($9.95) on an earnings per share basis.

How many employees does Rite Aid have?

Rite Aid employs 53,000 workers across the globe.

Does Rite Aid have any subsidiaries?

The following companies are subsidiares of Rite Aid: 1515 West State Street Boise Idaho LLC, 1740 Associates LLC, 4042 Warrensville Center Road—Warrensville Ohio Inc., 5277 Associates Inc., 5600 Superior Properties Inc., Advance Benefits LLC, Apex Drug Stores Inc., Ascend Health Technology LLC, Bartell Drugs, Broadview and Wallings—Broadview Heights Ohio Inc., Design Rx Holdings LLC, Design Rx LLC, Design Rxclusives LLC, Drug Palace Inc., EDC Drug Stores Inc., Eckerd Corporation, Edgehill Drugs, Elixir Insurance Company, Elixir Pharmacy LLC, Elixir Rx Options LLC, Elixir Rx Solutions LLC, Elixir Rx Solutions LLC, Elixir Rx Solutions of Nevada LLC, Elixir Savings LLC, Envision Pharmaceutical, Envision Pharmaceutical Holdings LLC, EnvisionRx Puerto Rico Inc., First Florida Insurers of Tampa LLC, GDF Inc., Genovese Drug Stores Inc., Gettysburg and Hoover-Dayton Ohio LLC, Grand River & Fenkell LLC, Harco, Harco Inc., Health Dialog, Health Dialog Services Corporation, Hunter Lane LLC, ILG – 90 B Avenue Lake Oswego LLC, JCG (PJC) USA LLC, JCG Holdings (USA) Inc., K&B Alabama Corporation, K&B Incorporated, K&B Industries, K&B Louisiana Corporation, K&B Mississippi Corporation, K&B Services Incorporated, K&B Tennessee Corporation, K&B Texas Corporation, LMW – 90B Avenue Lake Oswego Inc., Lakehurst and Broadway Corporation, Laker Software LLC, Maxi Drug Inc., Maxi Drug North Inc., Maxi Drug South L.P., Maxi Green Inc., Munson & Andrews LLC, Name Rite LLC, P.J.C. Distribution Inc., P.J.C. Realty Co. Inc., PCS Health Systems, PDS-1 Michigan Inc., PJC Lease Holdings Inc., PJC Manchester Realty LLC, PJC Peterborough Realty LLC, PJC Realty MA Inc., PJC Revere Realty LLC, PJC Special Realty Holdings Inc., PJC of Massachusetts Inc., PJC of Rhode Island Inc., PJC of Vermont Inc., Perry Distributors Inc., Perry Drug Stores Inc., RCMH LLC, RDS Detroit Inc., READ’s Inc., RediClinic, RediClinic Associates Inc., RediClinic LLC, RediClinic US LLC, RediClinic of DC LLC, RediClinic of DE LLC, RediClinic of Dallas Forth-Worth LLC, RediClinic of MD LLC, RediClinic of PA LLC, RediClinic of VA LLC, Richfield Road – Flint Michigan LLC, Rite Aid Drug Palace Inc., Rite Aid Hdqtrs. Corp., Rite Aid Hdqtrs. Funding Inc., Rite Aid Lease Management Company, Rite Aid Online Store Inc., Rite Aid Payroll Management Inc., Rite Aid Realty Corp., Rite Aid Rome Distribution Center Inc., Rite Aid Specialty Pharmacy LLC, Rite Aid Transport Inc., Rite Aid of Connecticut Inc., Rite Aid of Delaware Inc., Rite Aid of Georgia Inc., Rite Aid of Indiana Inc., Rite Aid of Kentucky Inc., Rite Aid of Maine Inc., Rite Aid of Maryland Inc., Rite Aid of Michigan Inc., Rite Aid of New Hampshire Inc., Rite Aid of New Jersey Inc., Rite Aid of New York Inc., Rite Aid of North Carolina Inc., Rite Aid of Ohio Inc., Rite Aid of Pennsylvania LLC, Rite Aid of South Carolina Inc., Rite Aid of Tennessee Inc., Rite Aid of Vermont Inc., Rite Aid of Virginia Inc., Rite Aid of Washington D.C. Inc., Rite Aid of West Virginia Inc., Rite Investments Corp., Rite Investments Corp. LLC, Rx Choice Inc., Rx Initiatives LLC, Rx USA Inc., The Bartell Drug Company, The Jean Coutu Group (PJC) USA Inc., The Lane Drug Company, Thrift Drug Inc., Thrifty Corporation, and Thrifty PayLess Inc..

When was Rite Aid founded?

Rite Aid was founded in 1968.

What is Rite Aid's official website?

The official website for Rite Aid is www.riteaid.com.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at (717) 761-2633, via email at [email protected], or via fax at 717-975-5871.